The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Two phase I/II open label clinical trials evaluating the safety and efficacy of autologous T cells expressing enhanced TCRs specific for NY-ESO-1 or MAGE-A10 in subjects with stage IIIb or stage IV non-small cell lung cancer (NCT02588612/NCT02592577).
 
Ben C. Creelan
Consulting or Advisory Role - Boehringer Ingelheim; Celgene
Speakers' Bureau - ARIAD; AstraZeneca/MedImmune; Bristol-Myers Squibb
Research Funding - Boehringer Ingelheim
Travel, Accommodations, Expenses - AstraZeneca
 
Justin F. Gainor
Honoraria - ARIAD; Incyte; Merck
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Genentech; Loxo; Novartis; Theravance
Research Funding - Adaptimmune; ARIAD; AstraZeneca; Bristol-Myers Squibb; Genentech; Merck; Novartis
Travel, Accommodations, Expenses - Affymetrix
 
Ramaswamy Govindan
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Abbvie; Bayer; Boehringer Ingelheim; Celgene; Clovis Oncology; Genentech/Roche; GlaxoSmithKline; Helsinn Therapeutics; Novartis
Research Funding - Abbvie (Inst); Bayer (Inst); GlaxoSmithKline (Inst); MethylGene (Inst)
Travel, Accommodations, Expenses - Amgen; Boehringer Ingelheim; Celgene; Genentech; GlaxoSmithKline; Merck
 
Nancy M. Hardy
No Relationships to Disclose
 
John Heymach
Stock and Other Ownership Interests - Bio-Tree; Cardinal Spine
Consulting or Advisory Role - Abbvie; ARIAD; AstraZeneca; AstraZeneca; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Calithera Biosciences; Genentech; Medivation; Novartis; Oncomed; Synta
Research Funding - AstraZeneca (Inst)
 
Raja Mudad
Honoraria - Celgene
Consulting or Advisory Role - AstraZeneca; Celgene; Genentech/Roche; Genoptix
Speakers' Bureau - Celgene
 
Karen L. Reckamp
Consulting or Advisory Role - Amgen; ARIAD; Astellas Pharma; Boehringer Ingelheim; Euclises; Nektar
Research Funding - Adaptimmune (Inst); ARIAD (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Eisai (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst); Xcovery (Inst)
 
William Bardwell
Employment - Adaptimmune
Stock and Other Ownership Interests - Adaptimmune
 
Tom Holdich
Employment - Adaptimmune
Stock and Other Ownership Interests - Adaptimmune
 
Arundathy N. Bartlett-Pandite
Employment - Adaptimmune; GlaxoSmithKline
Stock and Other Ownership Interests - Adaptimmune; GlaxoSmithKline
 
Rafael G. Amado
Employment - Adaptimmune; Adaptimmune
Stock and Other Ownership Interests - Adaptimmune; GlaxoSmithKline